Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects.
about
Role of melatonin in schizophreniaBlood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia.Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcomeVitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.Level of thyroid-stimulating hormone (TSH) in patients with acute schizophrenia, unipolar depression or bipolar disorderTranslating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders.Revisiting thyroid hormones in schizophrenia13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients.Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven reviewPeripheral amino Acid levels in schizophrenia and antipsychotic treatmentElevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?PRODH polymorphisms, cortical volumes and thickness in schizophrenia.Potential role of amino acids in pathogenesis of schizophrenia.Tryptophan Metabolism and White Matter Integrity in Schizophrenia.Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggression.Myopes have significantly higher serum melatonin concentrations than non-myopes.Profiling of Amino Acids and Their Derivatives Biogenic Amines Before and After Antipsychotic Treatment in First-Episode Psychosis.
P2860
Q26825564-D8677213-5386-41B2-A008-2DD3E59216BFQ30374523-355176CE-545B-4E4F-A3C5-BCD11E6B5322Q30464317-D7CC8D66-E06C-4D9A-A3BC-C608E8CAB57CQ33709226-3475DDAB-6E73-4C44-9135-36F5520CECA3Q33922084-1123ED6C-ABED-47FB-A823-68D38078B2BCQ34214660-96FBAC3D-DFDA-4183-92E3-6887AE57D9C0Q35876138-6F74B76D-E12C-4FC1-AD98-0EA1C3FC6DD0Q36001621-605A5D20-ACB3-4BA7-B277-8BE93DAE5B31Q36600817-89E13D12-AD2A-49BF-8F3D-190307DE39D4Q37483895-2956F8CF-F1F7-4D6C-9A3D-C33BD8F5D0A9Q37500605-4991A822-EDC8-405E-BF10-12A248C7CCB5Q37548891-285BB545-EB1C-4BD5-8963-C98E5095DC1AQ41706313-61DA9A3E-F157-4865-8B09-724903EF96EAQ41725053-F8C3D452-E071-4067-9D21-0F1CC36DF190Q44197234-EEEC3E41-C39C-4B72-BB2F-CC71904F46C9Q47614659-AB72CB66-0C00-44C8-9E85-F10455EC1BD8Q47708239-85206581-E188-4E47-B9FB-8067B794E999Q55188589-1D4EB47E-BD4C-4818-BC36-BD7A87CD442A
P2860
Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Serum amino acids, central mon ...... patients and healthy subjects.
@en
type
label
Serum amino acids, central mon ...... patients and healthy subjects.
@en
prefLabel
Serum amino acids, central mon ...... patients and healthy subjects.
@en
P2093
P1433
P1476
Serum amino acids, central mon ...... patients and healthy subjects.
@en
P2093
P304
P356
10.1016/0165-1781(90)90003-N
P407
P577
1990-12-01T00:00:00Z